Insmed Incorporated (INSM)

Insmed Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Revenue	305.21	245.36	188.46	164.41	136.47
Revenue Growth (YoY)	24.39%	30.19%	14.63%	20.48%	1287.56%
Cost of Revenue	65.57	55.13	44.15	39.87	24.21
Gross Profit	239.64	190.23	144.31	124.54	112.26
Selling, General & Admin	344.5	265.78	234.27	203.61	210.8
Research & Development	571.01	397.52	272.74	181.16	131.71
Other Operating Expenses	33.75	-15.75	12.39	5	4.99
Operating Expenses	949.26	647.55	519.4	389.77	347.5
Operating Income	-709.63	-457.32	-375.09	-265.23	-235.25
Interest Expense / Income	81.69	26.45	40.47	29.56	27.71
Other Expense / Income	-44.31	-3.62	20.85	-2.11	-9.39
Pretax Income	-747.01	-480.15	-436.41	-292.69	-253.56
Income Tax	2.56	1.38	-1.76	1.4	0.78
Net Income	-749.57	-481.53	-434.65	-294.09	-254.34
Shares Outstanding (Basic)	140	123	112	98	85
Shares Outstanding (Diluted)	140	123	112	98	85
Shares Change	14.14%	9.74%	14.86%	15.43%	9.98%
EPS (Basic)	-5.34	-3.91	-3.88	-3.01	-3.01
EPS (Diluted)	-5.34	-3.91	-3.88	-3.01	-3.01
Free Cash Flow	-549.54	-410.32	-370.59	-225.59	-292.92
Free Cash Flow Per Share	-3.91	-3.33	-3.31	-2.31	-3.46
Gross Margin	78.52%	77.53%	76.57%	75.75%	82.26%
Operating Margin	-232.51%	-186.39%	-199.03%	-161.32%	-172.38%
Profit Margin	-245.59%	-196.26%	-230.63%	-178.87%	-186.37%
Free Cash Flow Margin	-180.05%	-167.23%	-196.64%	-137.21%	-214.64%
EBITDA	-645.53	-431.4	-369.17	-243.04	-205.91
EBITDA Margin	-211.51%	-175.82%	-195.89%	-147.82%	-150.89%
Depreciation & Amortization	19.79	22.31	26.77	20.08	19.94
EBIT	-665.32	-453.71	-395.94	-263.12	-225.86
EBIT Margin	-217.99%	-184.92%	-210.09%	-160.04%	-165.50%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).